Barclays analyst Mark Devries downgrades Essent Gr (NYSE:ESNT) from Overweight to Equal-Weight and lowers the price target from $54 to $43.
Statement From Pfizer Chairman And CEO Albert Bourla On Testing Positive For COVID-19
I would like to inform the public that I have tested positive for COVID-19. I am grateful to have received four doses of the Pfizer-BioNTech vaccine and I am feeling well while experiencing very mild symptoms. I have